QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Quantum Biopharma Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026
$2.41−0.06 (-2.43%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Quantum Biopharma has not reported a dividend
No dividend per share appears in Quantum Biopharma's annual filings since fiscal 2018.